177 related articles for article (PubMed ID: 7955202)
1. Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
Markland FS; Friedrichs GS; Pewitt SR; Lucchesi BR
Circulation; 1994 Nov; 90(5):2448-56. PubMed ID: 7955202
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
Jackson CV; Frank JD; Craft TJ; Sundboom JL; Smith GF
J Pharmacol Exp Ther; 1992 Jan; 260(1):64-70. PubMed ID: 1731052
[TBL] [Abstract][Full Text] [Related]
3. Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis.
Werns SW; Rote WE; Davis JH; Guevara T; Lucchesi BR
Am Heart J; 1994 Apr; 127(4 Pt 1):727-37. PubMed ID: 8154409
[TBL] [Abstract][Full Text] [Related]
4. Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.
Yasuda T; Gold HK; Leinbach RC; Saito T; Guerrero JL; Jang IK; Holt R; Fallon JT; Collen D
J Am Coll Cardiol; 1990 Dec; 16(7):1728-35. PubMed ID: 2123910
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
Sudo Y; Kilgore KS; Lucchesi BR
J Cardiovasc Pharmacol; 1995 Aug; 26(2):241-50. PubMed ID: 7475049
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.
Mickelson JK; Simpson PJ; Cronin M; Homeister JW; Laywell E; Kitzen J; Lucchesi BR
Circulation; 1990 Feb; 81(2):617-27. PubMed ID: 2105175
[TBL] [Abstract][Full Text] [Related]
7. Intravenous administration of the glycoprotein IIb-IIIa receptor antagonist 7E3 induces reperfusion of an acute thrombotic occlusion of the canine coronary artery.
Shetler TJ; Bailey BD; Jakubowski JA; Jackson CV
Thromb Res; 1998 Apr; 90(2):95-100. PubMed ID: 9684763
[TBL] [Abstract][Full Text] [Related]
8. TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.
Rebello SS; Driscoll EM; Lucchesi BR
Stroke; 1997 Sep; 28(9):1789-96. PubMed ID: 9303027
[TBL] [Abstract][Full Text] [Related]
9. Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.
Rebello SS; Huang J; Saito K; Saucedo JF; Bates ER; Lucchesi BR
Eur J Pharmacol; 1999 Jun; 374(3):399-410. PubMed ID: 10422784
[TBL] [Abstract][Full Text] [Related]
10. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
Haskel EJ; Prager NA; Sobel BE; Abendschein DR
Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
[TBL] [Abstract][Full Text] [Related]
11. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.
Nicolini FA; Lee P; Rios G; Kottke-Marchant K; Topol EJ
Circulation; 1994 Apr; 89(4):1802-9. PubMed ID: 8149546
[TBL] [Abstract][Full Text] [Related]
12. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation.
Yasuda T; Gold HK; Leinbach RC; Yaoita H; Fallon JT; Guerrero L; Napier MA; Bunting S; Collen D
Circulation; 1991 Mar; 83(3):1038-47. PubMed ID: 1900221
[TBL] [Abstract][Full Text] [Related]
13. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
14. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.
Rote WE; Werns SW; Davis JH; Feigen LP; Kilgore KS; Lucchesi BR
Cardiovasc Res; 1993 Mar; 27(3):500-7. PubMed ID: 8490951
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis.
Martin U; Sponer G; Strein K
J Am Coll Cardiol; 1992 Feb; 19(2):433-40. PubMed ID: 1732372
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis.
Shetler TJ; Crowe VG; Bailey BD; Jackson CV
Circulation; 1996 Oct; 94(7):1719-25. PubMed ID: 8840866
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation.
Yasuda T; Gold HK; Yaoita H; Leinbach RC; Guerrero JL; Jang IK; Holt R; Fallon JT; Collen D
J Am Coll Cardiol; 1990 Sep; 16(3):714-22. PubMed ID: 2117620
[TBL] [Abstract][Full Text] [Related]
19. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
Rote WE; Nedelman MA; Mu DX; Manley PJ; Weisman H; Cunningham MR; Lucchesi BR
Stroke; 1994 Jun; 25(6):1223-32; discussion 1233. PubMed ID: 8202985
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.
Mickelson JK; Simpson PJ; Lucchesi BR
J Mol Cell Cardiol; 1989 Apr; 21(4):393-405. PubMed ID: 2746660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]